Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.
Over the last 12 months, insiders at Roivant Sciences Ltd. have bought $0 and sold $600.19M worth of Roivant Sciences Ltd. stock.
On average, over the past 5 years, insiders at Roivant Sciences Ltd. have bought $20.14M and sold $497.07M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,000,000 shares for transaction amount of $40M was made by Dexcel Pharma Technologies Ltd. (director) on 2022‑11‑10.
2024-02-09 | Sale | Venker Eric | President & COO | 96,950 0.0129% | $10.92 | $1.06M | +0.93% | |
2024-01-02 | Sale | Ramaswamy Vivek | 10 percent owner | 3M 0.3648% | $11.05 | $33.15M | -3.70% | |
2023-10-05 | Sale | Venker Eric | Chief Operating Officer | 153,027 0.0189% | $10.11 | $1.55M | +2.54% | |
2023-10-03 | Sale | Venker Eric | Chief Operating Officer | 606,221 0.0758% | $10.25 | $6.21M | +2.59% | |
2023-10-02 | Sale | Venker Eric | Chief Operating Officer | 440,752 0.0581% | $10.80 | $4.76M | +1.62% | |
2023-09-28 | Sale | SVF Investments (UK) Ltd | 10 percent owner | 10M 1.2883% | $12.60 | $126M | -14.82% | |
2023-09-28 | Sale | QVT Financial LP | 10 percent owner | 8.44M 0.9967% | $11.55 | $97.48M | -14.82% | |
2023-09-28 | Sale | MANCHESTER KEITH S | director | 6.9M 0.8144% | $11.55 | $79.65M | -14.82% | |
2023-09-28 | Sale | QVT Financial LP | 10 percent owner | 10M 1.181% | $11.55 | $115.5M | -14.82% | |
2023-09-28 | Sale | Gold Daniel Allen | director | 10M 1.181% | $11.55 | $115.5M | -14.82% | |
2023-09-27 | Sale | Venker Eric | President & COO | 500,000 0.0633% | $13.02 | $6.51M | -18.95% | |
2023-09-08 | Sale | Venker Eric | Chief Operating Officer | 106,430 0.0133% | $12.19 | $1.3M | -15.00% | |
2023-09-08 | Sale | Kumar Rakhi | Chief Accounting Officer | 99,350 0.0124% | $12.18 | $1.21M | -15.00% | |
2023-09-06 | Sale | Venker Eric | Chief Operating Officer | 5,926 0.0008% | $11.85 | $70,223 | -9.08% | |
2023-09-05 | Sale | Venker Eric | Chief Operating Officer | 73,275 0.0096% | $11.92 | $873,438 | -8.68% | |
2023-09-05 | Sale | Kumar Rakhi | Chief Accounting Officer | 1,724 0.0002% | $12.00 | $20,688 | -8.68% | |
2023-09-01 | Sale | Venker Eric | Chief Operating Officer | 14,763 0.002% | $11.90 | $175,680 | -8.05% | |
2023-08-14 | Sale | Venker Eric | Chief Operating Officer | 59,811 0.0079% | $11.89 | $711,153 | -7.77% | |
2023-08-03 | Sale | Venker Eric | Chief Operating Officer | 44,629 0.006% | $11.93 | $532,424 | -6.04% | |
2023-08-03 | Sale | Kumar Rakhi | Chief Accounting Officer | 3,681 0.0005% | $12.00 | $44,172 | -6.04% |
SVF Investments (UK) Ltd | 10 percent owner | 73031667 9.0844% | $10.57 | 0 | 3 | |
Ramaswamy Vivek | 10 percent owner | 51929426 6.4595% | $10.57 | 0 | 3 | |
MANCHESTER KEITH S | director | 5023787 0.6249% | $10.57 | 0 | 3 | |
Venker Eric | President & COO | 532207 0.0662% | $10.57 | 0 | 51 | |
Kumar Rakhi | Chief Accounting Officer | 197950 0.0246% | $10.57 | 0 | 21 | |
QVT Financial LP | 10 percent owner | 100804 0.0125% | $10.57 | 0 | 5 | |
Gold Daniel Allen | director | 100804 0.0125% | $10.57 | 0 | 3 | |
Dexcel Pharma Technologies Ltd. | director | 102849443 12.7935% | $10.57 | 3 | 0 | +38.38% |
Oren Dan | 98840843 12.2948% | $10.57 | 1 | 0 | +22.38% | |
Sumitomo Chemical Co., Ltd. | 10 percent owner | 71251083 8.8629% | $10.57 | 0 | 1 | |
Gline Matthew | CEO | 1164009 0.1448% | $10.57 | 0 | 11 | |
VIKING GLOBAL INVESTORS LP | 10 percent owner | 641010 0.0797% | $10.57 | 0 | 1 | |
VIKING GLOBAL PERFORMANCE LLC | 10 percent owner | 641010 0.0797% | $10.57 | 0 | 1 | |
Pulik Richard | CFO | 223347 0.0278% | $10.57 | 0 | 2 |
SoftBank Investment Advisers | $769.75M | 9.06 | 73.03M | 0% | +$0 | 7.6 | |
Viking Global Investors | $731.15M | 8.61 | 69.37M | 0% | +$0 | 0.27 | |
QVT Financial | $703.23M | 8.28 | 66.72M | -40.72% | -$482.96M | 70.06 | |
BlackRock | $381.42M | 4.49 | 36.19M | +73.93% | +$162.13M | 0.01 | |
Morgan Stanley | $375.6M | 4.42 | 35.64M | +62.52% | +$144.49M | 0.03 | |
Fidelity Investments | $372.49M | 4.39 | 35.34M | -4.42% | -$17.24M | 0.03 | |
Helm Capital Management LLC | $210.8M | 2.48 | 20M | +5.26% | +$10.54M | 6.23 | |
State Street | $180.79M | 2.13 | 17.15M | +24.95% | +$36.11M | 0.01 | |
Patient Square Capital Lp | $128.89M | 1.52 | 12.23M | -3.25% | -$4.34M | 54.89 | |
Woodline Partners LP | $117.76M | 1.39 | 11.17M | +81.61% | +$52.92M | 1.11 | |
The Vanguard Group | $85.44M | 1.01 | 8.11M | +14.57% | +$10.86M | <0.01 | |
Kairos Capital Management Lp | $83.59M | 0.98 | 7.93M | -6.79% | -$6.09M | 40.02 | |
Baker Bros Advisors LP | $78.14M | 0.92 | 7.41M | -2.36% | -$1.89M | 0.98 | |
Geode Capital Management | $63.75M | 0.75 | 6.05M | +9.45% | +$5.51M | 0.01 | |
Anchorage Capital Group L L C | $50.94M | 0.6 | 4.83M | 0% | +$0 | 13.33 | |
Avoro Capital Advisors Llc | $49.02M | 0.58 | 4.65M | 0% | +$0 | 0.59 | |
PointState Capital LP | $42.65M | 0.5 | 4.05M | New | +$42.65M | 1.29 | |
Adage Capital Partners Gp L L C | $41.47M | 0.49 | 3.93M | -25.41% | -$14.13M | 0.08 | |
Loomis, Sayles & Company | $33.66M | 0.4 | 3.19M | +25.05% | +$6.74M | 0.05 | |
Citadel Advisors LLC | $33.09M | 0.39 | 3.14M | -9.83% | -$3.61M | 0.02 | |
Bvf Inc Il | $28.9M | 0.34 | 2.74M | 0% | +$0 | 0.21 | |
BNY Mellon | $27.7M | 0.33 | 2.63M | +99.31% | +$13.8M | 0.01 | |
Tejara Capital Ltd | $27.41M | 0.32 | 2.6M | +21.8% | +$4.91M | 9.29 | |
Whitefort Capital Management Lp | $25.2M | 0.3 | 2.39M | +50.28% | +$8.43M | 16.46 | |
Nuveen | $24.83M | 0.29 | 2.36M | -0.78% | -$193,967.62 | 0.01 | |
Bank of America | $23.72M | 0.28 | 2.25M | +195.54% | +$15.69M | <0.01 | |
Charles Schwab | $22.26M | 0.26 | 2.11M | +4.42% | +$942,107.36 | 0.01 | |
Prosight Management Lp | $19.6M | 0.23 | 1.86M | New | +$19.6M | 5.45 | |
Pertento Partners Llp | $19.27M | 0.23 | 1.83M | +107.92% | +$10M | 3.91 | |
Lakewood Capital Management, LP | $18.39M | 0.22 | 1.74M | +60.96% | +$6.96M | 1.64 | |
First Trust | $18.09M | 0.21 | 1.72M | -37.34% | -$10.78M | 0.02 | |
Northern Trust | $17.55M | 0.21 | 1.67M | +12.56% | +$1.96M | <0.01 | |
Penn Davis McFarland, Inc. | $17.29M | 0.2 | 1.64M | New | +$17.29M | 2.69 | |
Impax Asset Management Group | $16.86M | 0.2 | 1.6M | New | +$16.86M | 0.07 | |
Goldman Sachs | $15.8M | 0.19 | 1.5M | +262.85% | +$11.44M | <0.01 | |
Polar Capital | $15.81M | 0.19 | 1.5M | New | +$15.81M | 0.09 | |
RTW Investments, LP | $15.33M | 0.18 | 1.45M | 0% | +$0 | 0.23 | |
GHOST TREE CAPITAL LLC | $13.7M | 0.16 | 1.3M | +116.67% | +$7.38M | 4.45 | |
Philosophy Capital Management Llc | $12.96M | 0.15 | 1.23M | +52.11% | +$4.44M | 2.54 | |
ClearBridge Investments | $12.96M | 0.15 | 1.23M | New | +$12.96M | 0.01 | |
Ubs Asset Management Americas Inc | $12.06M | 0.14 | 1.14M | -0.19% | -$23,230.16 | <0.01 | |
TIFF Advisory Services Inc | $12.1M | 0.14 | 1.15M | New | +$12.1M | 5.28 | |
Franklin Templeton Investments | $12.01M | 0.14 | 1.14M | New | +$12.01M | <0.01 | |
Standard Life | $11.88M | 0.14 | 1.13M | 0% | +$0 | 0.02 | |
Assenagon Asset Management S.A. | $10.74M | 0.13 | 1.02M | -4.18% | -$468,956.20 | 0.03 | |
Renaissance Technologies | $10.63M | 0.13 | 1.01M | New | +$10.63M | 0.02 | |
Sofinnova | $10.56M | 0.12 | 1M | New | +$10.56M | 0.02 | |
RhumbLine Advisers | $10.09M | 0.12 | 957,349 | +127.05% | +$5.65M | 0.01 | |
JPMorgan Chase | $9.74M | 0.12 | 923,802 | +118.68% | +$5.28M | <0.01 | |
Rafferty Asset Management Llc | $9.61M | 0.11 | 912,193 | -6.26% | -$642,318.13 | 0.03 |